Synta Pharmaceuticals Corp (SNTA.OQ)
SNTA.OQ on NASDAQ Stock Exchange Global Market
6.69USD
1 Aug 2013
6.69USD
1 Aug 2013
Price Change (% chg)
$-0.02 (-0.30%)
$-0.02 (-0.30%)
Prev Close
$6.71
$6.71
Open
$6.64
$6.64
Day's High
$6.90
$6.90
Day's Low
$6.41
$6.41
Volume
66,222
66,222
Avg. Vol
461,196
461,196
52-wk High
$11.77
$11.77
52-wk Low
$3.77
$3.77
About
Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating... (more)
Overall
| Beta: | 2.64 |
| Market Cap (Mil.): | $463.89 |
| Shares Outstanding (Mil.): | 69.13 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| SNTA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -1.09 | -- | -- |
| ROI: | -112.85 | -2.58 | 18.76 |
| ROE: | -151.52 | -2.66 | 19.59 |
Synta Pharma shares soar after co says to expand breast cancer study
- Synta Pharmaceuticals Corp shares soared as much as 47 percent in heavy trading after the company said preliminary results from a mid-stage study of its drug ganetespib in breast cancer patients supported an expansion of the study.
Competitors
| Price | Change | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $94.15 | +0.65 |
| Amgen, Inc. (AMGN.OQ) | $108.85 | +0.56 |
| Abbott Laboratories (ABT.N) | $36.83 | +0.20 |
| Infinity Pharmaceuticals Inc. (INFI.OQ) | $21.17 | -0.01 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Kyowa Hakko Kirin Co Ltd (4151.T) | ¥1,000 | +22.00 |
| OXiGENE Inc (OXGN.OQ) | $2.79 | -0.02 |
| Sanofi SA (SASY.PA) | €76.91 | -3.26 |
| Wyeth Limited (WLED.NS) | Rs666.25 | -19.05 |
| Curis, Inc. (CRIS.OQ) | $4.17 | +0.02 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: Wright Reports
|
$460.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

